
Repro Med Systems KRMD
€ 2.68
-8.21%
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ CAPITAL |
Anteile |
46.2 M |
Marktkapitalisierung |
$ 139 M |
EBITDA (LTM) |
$ -2.16 M |
P/E (LTM) |
-54.166667 |
P/S (LTM) |
3.649833 |
EPS (LTM) |
-0.06 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 25.6 | -3.32 % | $ 13.1 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 212.18 | 1.97 % | $ 61 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 76.59 | -1.0 % | $ 37.8 B | NYSE | ||
|
Intuitive Surgical
ISRG
|
$ 468.54 | -2.81 % | $ 167 B | Nasdaq Global Select Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.06 | -5.59 % | $ 2.01 B | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 61.0 | -3.85 % | $ 197 B | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 239.21 | -0.52 % | $ 34.8 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.57 | -0.04 % | $ 17.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.68 | -1.8 % | $ 1.32 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.68 | 0.58 % | $ 385 M | Nasdaq Global Market | ||
|
Utah Medical Products
UTMD
|
$ 71.1 | -1.82 % | $ 230 M | Nasdaq Global Select Market | ||
|
InfuSystem Holdings
INFU
|
$ 13.53 | 2.89 % | $ 280 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 392.2 | -4.06 % | $ 28.4 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 130.43 | -2.66 % | $ 4.17 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 254.31 | 2.52 % | $ 25 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 8.82 | 4.94 % | $ 74.8 M | Nasdaq Global Select Market | ||
|
AtriCure
ATRC
|
$ 61.26 | -7.41 % | $ 2.93 B | Nasdaq Global Market,SPB | ||
|
The Cooper Companies
COO
|
$ 63.5 | -1.43 % | $ 12.6 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 220.0 | -10.84 % | $ 12.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.81 | -3.59 % | $ 490 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.36 | -9.68 % | $ 247 M | Nasdaq Global Select Market,SPB | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.07 | -6.14 % | $ 49 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 122.46 | -4.01 % | $ 5.78 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 167.41 | -3.02 % | $ 4.12 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.31 | -5.11 % | $ 25.4 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 89.65 | -1.08 % | $ 5.3 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 3.1 | -4.62 % | $ 32.9 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.93 | -8.51 % | $ 4.19 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 83.43 | -5.11 % | $ 1.89 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 52.71 | -7.63 % | $ 3.55 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 168.79 | -5.28 % | $ 9.49 B | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 152.14 | 1.43 % | $ 6.79 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 0.99 | 3.33 % | $ 90 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |